AC Immune (ACIU) Amortizatization of Intangibles (2019 - 2025)
Powered by 
Analysis
AC Immune (ACIU) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 407,881.35 |
| Sep 30, 2025 | 341,279.90 |
| Jun 30, 2025 | 314,051.46 |
| Mar 31, 2025 | 279,174.88 |
| Dec 31, 2024 | 194,058.71 |
| Sep 30, 2024 | 196,215.23 |
| Jun 30, 2024 | 187,984.89 |
| Mar 31, 2024 | 191,328.95 |
| Dec 31, 2023 | 155,574.92 |
| Sep 30, 2023 | 153,972.75 |
| Jun 30, 2023 | 150,143.70 |
| Mar 31, 2023 | 144,875.79 |
| Dec 31, 2022 | 148,437.13 |
| Sep 30, 2022 | 145,999.39 |
| Jun 30, 2022 | 147,437.61 |
| Mar 31, 2022 | 151,593.17 |
| Dec 31, 2021 | 153,999.30 |
| Sep 30, 2021 | 154,656.33 |
| Jun 30, 2021 | 129,404.36 |
| Mar 31, 2021 | 118,348.32 |